Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
615 JPY | -0.65% |
|
+1.49% | -47.53% |
Chart calendar JCR Pharmaceuticals Co., Ltd.
Upcoming events on JCR Pharmaceuticals Co., Ltd.
Past events on JCR Pharmaceuticals Co., Ltd.
2024-05-09 | Q4 2023 Earnings Release |
2024-03-27 | Final dividend |
2024-02-03 | WORLD Symposium |
2024-01-25 | Q3 2023 Earnings Release |
2023-10-24 | Q2 2023 Earnings Release |
2023-10-03 10:00 pm | JR-171 Phase I/II Study Results Call |
2023-09-27 | Détachement de for dividende intermédiaire |
2023-07-25 | Q1 2023 Earnings Release |
2023-05-10 | Q4 2022 Earnings Release |
2023-03-29 | Détachement de for final dividend |
2023-01-30 | Q3 2022 Earnings Release |
2022-10-25 | Interim 2022 Earnings Release |
2022-09-28 | Détachement de for dividende intermédiaire |
2022-07-26 | Q1 2022 Earnings Release |
2022-05-11 | FY 2021 Earnings Release |
2022-03-29 | Détachement de for final dividend |
2022-02-10 06:00 pm | WORLD Symposium - Poster No - 205 |
2022-02-10 06:00 pm | WORLD Symposium - Poster No - 89 |
2022-02-09 06:00 pm | WORLD Symposium - Poster No - 135 |
2022-02-09 06:00 pm | WORLD Symposium - Poster No - 113 |
Past dividends on JCR Pharmaceuticals Co., Ltd.
2024-03-27 | Final Payment 10 JPY |
2023-09-27 | Interim Payment 10 JPY |
2023-03-29 | Final Payment 10 JPY |
2022-09-28 | Interim Payment 10 JPY |
2022-03-29 | Bonus Payment 2 JPY |
2022-03-29 | Final Payment 10 JPY |
2021-09-28 | Interim Payment 10 JPY |
2021-03-29 | Bonus Payment 0.5 JPY |
2021-03-29 | Final Payment 7 JPY |
2020-09-28 | Interim Payment 18 JPY |
Annual results
Fiscal Period | March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net sales Million JPY | Released Forecast Spread | 24 781 25 470 -2.71% | 30 085 27 769 8.34% | 51 082 49 841 2.49% | 34 343 38 989 -11.92% | 42 871 45 366 -5.5% | 41 487 |
EBITDA Million JPY | Released Forecast Spread | 4 678 5 564 -15.92% | 10 161 8 476 19.88% | 21 878 24 774 -11.69% | 6 972 11 924 -41.53% | 10 728 12 432 -13.71% | 8 667 |
EBIT Million JPY | Released Forecast Spread | 3 244 4 109 -21.05% | 8 269 6 830 21.07% | 19 933 22 768 -12.45% | 4 975 10 210 -51.27% | 7 531 10 386 -27.49% | 6 280 |
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 3 422 3 962 -13.63% | 8 653 6 773 27.75% | 19 404 22 522 -13.84% | 5 412 9 469 -42.84% | 7 244 9 900 -26.83% | 6 392 |
Net income Million JPY | Released Forecast Spread | 2 678 3 322 -19.4% | 6 892 5 400 27.64% | 14 507 15 578 -6.87% | 3 772 7 575 -50.2% | 5 507 7 245 -23.99% | 4 762 |
EPS JPY | Released Forecast Spread | 21,7 26,5 -18.08% | 55,8 43,8 27.32% | 117 126 -6.91% | 30,4 61,1 -50.31% | 44,1 58,2 -24.12% | 38,2 |
Announcement Date | 12/05/20 | 13/05/21 | 12/05/22 | 11/05/23 | 10/05/24 | - |
Quarterly results
Fiscal Period | March | 2021 S1 | 2021 S2 | 2022 S1 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million JPY | Released Forecast Spread | 10 951 | 19 134 17 299 10.61% | 28 383 | 10 812 12 250 -11.74% | 22 699 24 247 -6.38% | 9 606 9 430 1.87% | 5 975 8 278 -27.82% | 15 581 | 11 115 10 696 3.92% | 7 647 8 627 -11.35% | 18 762 18 909 -0.78% | 10 808 | 13 464 11 000 22.4% | 24 272 | 9 446 13 000 -27.34% | 9 153 12 382 -26.08% | 18 599 22 628 -17.81% | 11 300 | 11 300 | 11 300 | 10 100 |
EBIT Million JPY | Released Forecast Spread | 1 307 | 6 962 3 630 91.79% | 13 640 | 1 577 4 295 -63.28% | 6 293 8 800 -28.49% | 1 536 3 286 -53.26% | -792 1 196 -166.25% | 744 | 4 209 6 418 -34.42% | 22,0 1 106 -98.01% | 4 231 5 072 -16.58% | 2 066 | 4 832 2 800 72.57% | 6 898 | 911 3 400 -73.21% | -278 3 066 -109.07% | 633 4 252 -85.11% | 2 800 | 2 800 | 2 800 | -1 400 |
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 1 381 | 7 272 6 055 20.1% | 12 729 | 1 682 4 176 -59.72% | 6 675 9 169 -27.2% | 2 083 | 1 560 | 3 720 | 132 1 425 -90.74% | 3 852 5 145 -25.13% | 2 260 | 7 120 | 251 | -127 3 162 -104.02% | 124 3 413 -96.37% | ||||||
Net income Million JPY | Released Forecast Spread | 1 227 | 5 665 4 503 25.81% | 9 234 | 1 586 3 069 -48.32% | 5 273 6 756 -21.95% | 1 368 | -406 945 -142.96% | 962 | 2 606 | 204 1 452 -85.95% | 2 810 4 058 -30.75% | 1 610 | 3 643 2 000 82.15% | 5 253 | -93,0 2 400 -103.88% | 347 2 380 -85.42% | 254 2 627 -90.33% | 2 100 | 2 100 | 2 100 | -1 000 |
EPS JPY | Released Forecast Spread | 9,94 | 45,9 36,5 25.67% | 74,7 | 12,8 24,8 -48.35% | 42,6 54,6 -21.98% | 11,1 | -3,29 7,60 -143.29% | 7,77 | 21,0 | 1,62 6,80 -76.18% | 22,6 32,5 -30.52% | 12,9 | 29,2 16,0 82.12% | 42,1 | -0,75 11,4 -106.59% | 2,78 16,7 -83.34% | 16,8 | 16,8 | 16,8 | -8,01 | |
Announcement Date | 26/10/20 | 13/05/21 | 28/10/21 | 12/05/22 | 12/05/22 | 27/07/22 | 26/10/22 | 26/10/22 | 31/01/23 | 11/05/23 | 11/05/23 | 26/07/23 | 25/10/23 | 25/10/23 | 26/01/24 | 10/05/24 | 10/05/24 | - | - | - | - |
Past sector events for JCR Pharmaceuticals Co., Ltd.
2024-06-21 11:28 am | DEVA HOLDING: Q1 2024 Earnings Release |
2024-06-13 05:21 pm | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
2024-06-11 01:30 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-07 06:33 am | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
2024-06-07 05:17 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
2024-05-30 08:08 am | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
2024-05-30 07:00 am | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
2024-05-30 02:24 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
2024-05-29 08:00 am | FDC LIMITED: Q4 2024 Earnings Release |
2024-05-29 05:26 am | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4552 Stock
- Calendar JCR Pharmaceuticals Co., Ltd.